Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 5/6/20231 min de lectura
Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals; Guidance for Industry; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Nonclinical Evaluation of the Immunotoxic Potential of Pharmaceuticals." This guidance finalizes the draft guidance entitled "Nonclinical Safety Evaluation of the Immunotoxic Potential of Drugs and Biologics" issued on February 20, 2020.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →